Australia: Market for Medicaments Of Alkaloids Or Derivatives Thereof 2022

Market Size for Medicaments Of Alkaloids Or Derivatives Thereof in Australia

The Australian market for medicaments of alkaloids or derivatives thereof expanded rapidly to $X in 2021, surging by X% against the previous year. In general, consumption, however, recorded a noticeable slump. Consumption of peaked at $X in 2012; however, from 2013 to 2021, consumption remained at a lower figure.

Production of Medicaments Of Alkaloids Or Derivatives Thereof in Australia

In value terms, production of medicaments of alkaloids or derivatives thereof soared to $X in 2021 estimated in export price. In general, production, however, continues to indicate a perceptible decline. The growth pace was the most rapid in 2019 with an increase of X% against the previous year. Over the period under review, production of reached the peak level at $X in 2012; however, from 2013 to 2021, production stood at a somewhat lower figure.

Exports of Medicaments Of Alkaloids Or Derivatives Thereof

Exports from Australia

In 2021, overseas shipments of medicaments of alkaloids or derivatives thereof increased by X% to X tons, rising for the fourth year in a row after two years of decline. In general, exports continue to indicate noticeable growth. The growth pace was the most rapid in 2018 with an increase of X% against the previous year. The exports peaked in 2021 and are expected to retain growth in the near future.

In value terms, exports of medicaments of alkaloids or derivatives thereof stood at $X in 2021. Over the period under review, exports, however, saw a deep reduction. The pace of growth appeared the most rapid in 2018 with an increase of X%. Over the period under review, the exports of hit record highs at $X in 2012; however, from 2013 to 2021, the exports remained at a lower figure.

Exports by Country

Saudi Arabia (X tons) was the main destination for exports of medicaments of alkaloids or derivatives thereof from Australia, accounting for a X% share of total exports. Moreover, exports of medicaments of alkaloids or derivatives thereof to Saudi Arabia exceeded the volume sent to the second major destination, China (X tons), threefold. The third position in this ranking was held by Poland (X tons), with a X% share.

From 2012 to 2021, the average annual growth rate of volume to Saudi Arabia amounted to +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: China (+X% per year) and Poland (+X% per year).

In value terms, the largest markets for medicaments of alkaloids or derivatives thereof exported from Australia were China ($X), Saudi Arabia ($X) and Poland ($X), with a combined X% share of total exports.

Among the main countries of destination, China, with a CAGR of +X%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced mixed trend patterns.

Export Prices by Country

In 2021, the average export price for medicaments of alkaloids or derivatives thereof amounted to $X per ton, remaining constant against the previous year. In general, the export price recorded a abrupt shrinkage. The most prominent rate of growth was recorded in 2013 an increase of X% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2014 to 2021, the the average export prices remained at a lower figure.

There were significant differences in the average prices for the major foreign markets. In 2021, the country with the highest price was the United States ($X per ton), while the average price for exports to Fiji ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to China (-X%), while the prices for the other major destinations experienced a decline.

Imports of Medicaments Of Alkaloids Or Derivatives Thereof

Imports into Australia

For the seventh year in a row, Australia recorded growth in purchases abroad of medicaments of alkaloids or derivatives thereof, which increased by X% to X tons in 2021. Over the period under review, total imports indicated a buoyant expansion from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2012 indices. The most prominent rate of growth was recorded in 2016 with an increase of X% against the previous year. Imports peaked in 2021 and are expected to retain growth in years to come.

In value terms, imports of medicaments of alkaloids or derivatives thereof shrank modestly to $X in 2021. In general, imports, however, saw a noticeable descent. The most prominent rate of growth was recorded in 2014 when imports increased by X% against the previous year. As a result, imports reached the peak of $X. From 2015 to 2021, the growth of imports of remained at a somewhat lower figure.

Imports by Country

In 2021, India (X tons) constituted the largest supplier of medicaments of alkaloids or derivatives thereof to Australia, with a X% share of total imports. Moreover, imports of medicaments of alkaloids or derivatives thereof from India exceeded the figures recorded by the second-largest supplier, the UK (X tons), fourfold. New Zealand (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2021, the average annual rate of growth in terms of volume from India amounted to +X%. The remaining supplying countries recorded the following average annual rates of imports growth: the UK (-X% per year) and New Zealand (-X% per year).

In value terms, the largest medicaments of alkaloids or derivatives thereof suppliers to Australia were the UK ($X), Germany ($X) and India ($X), together comprising X% of total imports.

Germany, with a CAGR of +X%, saw the highest growth rate of the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for medicaments of alkaloids or derivatives thereof stood at $X per ton in 2021, declining by -X% against the previous year. Overall, the import price continues to indicate a abrupt setback. The most prominent rate of growth was recorded in 2014 an increase of X% against the previous year. Over the period under review, average import prices attained the peak figure at $X per ton in 2012; however, from 2013 to 2021, import prices stood at a somewhat lower figure.

Prices varied noticeably country of origin: the country with the highest price was the United States ($X per ton), while the price for India ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Germany (+X%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :